Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • fishmercedriver fishmercedriver Feb 28, 2012 1:09 PM Flag

    AEZS has a excellent chance in 2012

    Chance for FDA approval in the US for Perifosine in CRC treatment, Chance for approval for Perifosine in Europe for CRC treatment, Chance for approval for AEZS-130 NDA in the US, Chance for AEZS-108 to move to phase III in the US.

    Chance for Perifosine approval in MM in 2013, a 2012 surprise would be nice. Chance for Perifosine approval in MENA, Korea and Japan.

    It' difficult to put a price on the stock, we'll see what happens.

 
AEZS
2.89+0.04(+1.40%)Feb 12 4:00 PMEST